The conventional RAS (ACE/Ang II/AT1R) axis activation in parallel with nonconventional (ACE2/Ang 1–7/Mas) axis down-regulation was proposed to be the underlying factor leading to severe COVID-19 outcome in hypertension [41,42]. The gene discussed is ANGPT1; the disease is hypertensive disorder.